These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15268643)

  • 1. Strategic Research Institute G-Protein-Coupled Receptors Drug Discovery World Summit.
    Felder CC
    Expert Opin Investig Drugs; 2004 Aug; 13(8):1071-4. PubMed ID: 15268643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily.
    Roth BL; Kroeze WK
    J Biol Chem; 2015 Aug; 290(32):19471-7. PubMed ID: 26100629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
    Bodovitz S
    IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.
    Newman AH; Battiti FO; Bonifazi A
    J Med Chem; 2020 Mar; 63(5):1779-1797. PubMed ID: 31499001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptors: new approaches to maximise the impact of GPCRS in drug discovery.
    Davey J
    Expert Opin Ther Targets; 2004 Apr; 8(2):165-70. PubMed ID: 15102557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based and fragment-based GPCR drug discovery.
    Andrews SP; Brown GA; Christopher JA
    ChemMedChem; 2014 Feb; 9(2):256-75. PubMed ID: 24353016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal Chemistry - XXIst International Symposium.
    Chan D
    IDrugs; 2010 Nov; 13(11):749-52. PubMed ID: 21046517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico approaches in G protein-coupled receptors (GPCRs) drug discovery: quo vadis?
    Moro S
    Curr Pharm Des; 2009; 15(35):3992-3. PubMed ID: 20028317
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Diseases Drug Discovery World Summit.
    Liu G
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):577-82. PubMed ID: 14662006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic.
    Terrett NK
    IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648
    [No Abstract]   [Full Text] [Related]  

  • 20. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.